INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 95 filers reported holding INSTIL BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $413 | -77.8% | 966 | -71.4% | 0.00% | – |
Q2 2023 | $1,859 | -97.1% | 3,374 | -96.5% | 0.00% | – |
Q1 2023 | $64,441 | +102.1% | 97,637 | +93.0% | 0.00% | – |
Q4 2022 | $31,878 | -61.1% | 50,601 | +197.4% | 0.00% | – |
Q3 2022 | $82,000 | -5.7% | 17,013 | -9.9% | 0.00% | – |
Q2 2022 | $87,000 | -72.8% | 18,872 | -36.5% | 0.00% | – |
Q1 2022 | $320,000 | -17.1% | 29,742 | +31.9% | 0.00% | – |
Q4 2021 | $386,000 | +865.0% | 22,553 | +920.0% | 0.00% | – |
Q3 2021 | $40,000 | -24.5% | 2,211 | -19.3% | 0.00% | – |
Q2 2021 | $53,000 | – | 2,739 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |